MMADHC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.449200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.413600E-01
Normal-vs-Stage2
8.917600E-01
Normal-vs-Stage3
4.097200E-01
Normal-vs-Stage4
5.822200E-01
Stage1-vs-Stage2
7.483000E-01
Stage1-vs-Stage3
5.166000E-01
Stage1-vs-Stage4
5.624600E-01
Stage2-vs-Stage3
2.498200E-01
Stage2-vs-Stage4
5.878400E-01
Stage3-vs-Stage4
1.929230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.664600E-01
Normal-vs-AfricanAmerican
7.420800E-01
Normal-vs-Asian
9.809600E-01
Caucasian-vs-AfricanAmerican
6.734400E-01
Caucasian-vs-Asian
9.992000E-01
AfricanAmerican-vs-Asian
8.190600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.319400E-01
Normal-vs-Female
9.555400E-01
Male-vs-Female
9.019800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.381800E-01
Normal-vs-Age(41-60Yrs)
6.942600E-01
Normal-vs-Age(61-80Yrs)
9.393800E-01
Normal-vs-Age(81-100Yrs)
8.847400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.926440E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.810800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.462200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.552100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.793200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.169600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.494600E-01
Normal-vs-Daily Drinker
7.652000E-01
Normal-vs-Weekly Drinker
6.561600E-01
Normal-vs-Occasional Drinker
3.194200E-01
Normal-vs-Social Drinker
7.976600E-01
Non Drinker-vs-Daily Drinker
9.589200E-01
Non Drinker-vs-Weekly Drinker
7.076400E-01
Non Drinker-vs-Occasional Drinker
7.182100E-03
Non Drinker-vs-Social Drinker
8.875000E-01
Daily Drinker-vs-Weekly Drinker
7.744200E-01
Daily Drinker-vs-Occasional Drinker
1.711890E-02
Daily Drinker-vs-Social Drinker
8.678400E-01
Weekly Drinker-vs-Occasional Drinker
1.847770E-02
Weekly Drinker-vs-Social Drinker
6.586800E-01
Occasional Drinker-vs-Social Drinker
2.735800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.922200E-01
Normal-vs-Grade 2
2.667600E-02
Normal-vs-Grade 3
9.418600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.661700E-03
Grade 1-vs-Grade 3
2.361100E-03
Grade 1-vs-Grade 4
1.922200E-01
Grade 2-vs-Grade 3
7.113000E-01
Grade 2-vs-Grade 4
2.667600E-02
Grade 3-vs-Grade 4
9.418600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.842000E-01
Normal-vs-NonDiabetic
9.893400E-01
Diabetic-vs-NonDiabetic
6.868800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.258200E-01
Normal-vs-NoPancreatitis
9.734600E-01
Pancreatitis-vs-NoPancreatitis
4.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.986600E-01
Normal-vs-N1
8.934800E-01
N0-vs-N1
6.402400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.529000E-01
Normal-vs-TP53-NonMutant
8.751400E-01
TP53-Mutant-vs-TP53-NonMutant
2.06309999999377E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
